Skip to content

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614000449639
Acronym
NA
Enrollment
600
Registered
2014-05-01
Start date
2014-03-27
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Conditions of temporary glucose intolerance - such as gestational diabetes - identify people who are at risk from subsequently developing type 2 diabetes. This is important as the prompt diagnosis of glucose intolerance allows earlier treatment and a consequent reduction in complications associated with prolonged and untreated hyperglycaemia, dyslipidaemia and hypertension. The possibility that critical illness-associated hyperglycaemia (CIAH) could be a risk factor for subsequent type 2 diabetes has only been evaluated in one study. This study however has substantial limitations, which severely restrict interpretation of these data. If CIAH is a risk factor for development of type 2 diabetes, and the mechanisms underlying any glucose intolerance elucidated, survivors could be screened for diabetes and prompt appropriate therapy instituted.

Interventions

Blood test (HBA1c & Fasting Lipids), Oral Glucose tolerance test , Isotope breath test and height, weight and blood pressure will be measured at 3 months, 1, 2, 3, 6 and 10 years of health and unhealthy volunteers.

Sponsors

Dr Adam Deane
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Critical Illness-associated hyperglycaemia: HbA1c < 6.5%, blood glucose concentrations > 11.1 mmol/l for at least two consecutive readings during ICU admission Normoglycaemic: HbA1c < 6.5%, fasted blood glucose concentrations remain < 7.1mmol/l and random concentrations remain < 11.1 mmol/l throughout ICU admission Healthy volunteers: >18 years of age, sex and BMI will be used to match volunteers

Exclusion criteria

Inability to give informed consent, current pregnancy, previous gestational diabetes, acute or chronic pancreatitis, medications known to affect glucose metabolism (e.g. steroids)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026